Ledger.Open graph →
SEC Form D · filed August 30, 2016

KinDex Pharmaceuticals, Inc

Offering
$600K
Sold
$327K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Paul J. Schimmel · Seattle, WADirectorJeffrey J. Katke · Seattle, WADirectorJeffrey S. Bland · Seattle, WAExec · DirectorLincoln J. Bouillon · Seattle, WAExecMichael J. Higgins · Seattle, WADirectorRoger S. Colman · Seattle, WADirectorNeile A. Grayson · Seattle, WAExecBetsy Biemann · Brunswick, MEDirectorVerne O. Sedlacek · WILTON, CTExecJeffrey T. Long · WILTON, CTDirectorJohn W. Auchincloss · WILTON, CTExec · DirectorA. N. De Monico · WILTON, CTExecJames T. Hickey · Houston, TXDirectorJay T. Jackson · Houston, TXDirectorKyle J. Cunningham · Glen Mills, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗